NucliRay Defence IVS: Financial statements 2020
CVR: 37175439
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
NucliRay Defence IVS (CVR 37175439) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK 0 compared with DKK -1,896 the year before. Equity in the 2020 report amounted to DKK 68,133. The solvency ratio was 100%.
- Profit/Loss
- DKK 0
- Equity
- DKK 68,133
- Total Assets
- DKK 68,133
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | - | 0 | 68K | - |
| 2019 | 0 | -2K | -2K | 68K | - |
| 2018 | 0 | -4K | -4K | 70K | - |
| 2017 | 0 | -61K | -61K | 65K | - |
| 2016 | 0 | -66K | -133K | 71K | - |
Official annual report
How creditworthy is NucliRay Defence IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
NucliRay Defence IVS has published its annual report for 2019. Revenue came to DKK 0, and the net result was DKK -1,896.
About NucliRay Defence IVS
NucliRay Defence IVS was a Danish company of the type Iværksætterselskab based in København K, founded in 2015. The company has been dissolved on 6 May 2022. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2020, the company reported a net result of DKK 0 compared with DKK -1,896 the year before. Equity in the 2020 report amounted to DKK 68,133.